Calamos Advisors LLC - ISIS PHARMACEUTICALS INC DEL ownership

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q2 2020$1,934,000
-29.2%
1,750,000
-35.0%
0.01%
-33.3%
Q1 2020$2,732,000
-19.2%
2,693,000
-8.7%
0.02%
+23.5%
Q4 2019$3,383,000
-93.8%
2,950,000
-93.9%
0.02%
-94.3%
Q3 2019$54,824,000
-3.8%
48,113,000
+0.1%
0.30%
-5.4%
Q2 2019$56,972,000
+2.1%
48,074,000
+16.7%
0.32%
-9.2%
Q1 2019$55,801,000
+85.2%
41,197,000
+47.1%
0.35%
+74.9%
Q4 2018$30,136,000
+20.6%
28,007,000
+18.7%
0.20%
+45.3%
Q3 2018$24,993,000
+7.9%
23,600,0000.0%0.14%
-3.5%
Q2 2018$23,171,000
-0.7%
23,600,0000.0%0.14%
-6.6%
Q1 2018$23,343,000
-6.7%
23,600,0000.0%0.15%
+18.8%
Q4 2017$25,028,000
+34.7%
23,600,000
+34.9%
0.13%
-11.1%
Q3 2017$18,584,000
-0.3%
17,500,0000.0%0.14%
+4.3%
Q2 2017$18,648,000
+10.4%
17,500,0000.0%0.14%
+3.8%
Q1 2017$16,898,000
-5.6%
17,500,0000.0%0.13%
-6.3%
Q4 2016$17,896,000
+9.4%
17,500,0000.0%0.14%
+21.4%
Q3 2016$16,353,000
+32.2%
17,500,0000.0%0.12%
+34.5%
Q2 2016$12,373,000
-39.7%
17,500,000
-22.1%
0.09%
-36.0%
Q1 2016$20,529,000
-19.1%
22,479,000
-0.1%
0.14%
-15.5%
Q4 2015$25,390,00022,507,0000.16%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2023
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders